Moderna's stock dropped despite exceeding Q3 earnings forecasts, possibly due to higher Covid-19 vaccination rates last year. CEO Stéphane Bancel dismissed worries about Robert F. Kennedy Jr. impacting vaccine uptake, affirming Moderna's collaboration with government. U.S.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing